EQA Programme 2021

Labquality’s external quality assessment programme (EQAS) is aimed at medical laboratories and point of care testing sites. The programme includes more than 170 clinically relevant external quality assessment schemes and it is fully compliant with ISO15189 standard requirements.

Subscription for 2021 is open

Please subscribe EQA programs 2021 before the end of November 2020 to ensure your participation to all needed EQA rounds. You can renew your subscription by contacting our local partner in your country. Direct customers of Labquality can renew their subscription in LabScala. If you need more information, please contact to our customer service info@labquality.fi

Changes in the 2021 programme

New schemes and products

Discontinued schemes and products

  • 2370 Folate, erythrocytes
  • 3201 Urine, identification of cells and other particles, paper prints

Planned pilot schemes

Information about pilot contents and schedules will be announced later. Pilot schemes are EQA schemes under our product development.

  • Microbiology – Virology: SARS-CoV-2, antigen detection
  • Microbiology – Virology: CMV and EBV, nucleic acid detection
  • Microbiology – Bacterial serology: Francisella tularensis, antibodies
  • Microbiology – Mycology: Fungal infection, virtual microscopy pilot study (native and fluorescence)
  • Haematology – Coagulation: INR, qLabs, POCT
  • Clinical chemistry – Special chemistry: Serum Hepcidin
  • Clinical chemistry – Special chemistry: Gastropanel pilot study (analytes: Pepsinogen I and II, Gastrin-17, H. Pylori)


All changes are listed in the Product Cataloque 2021 on page 5. Please download the catalogue from the button below.


Contact us


Pin It on Pinterest

Share This